The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research
Eric Groce
- Vol. 104, Iss: 4, pp 32-32
Reads0
Chats0
TLDR
Despite increased cannabis use and a changing state-level policy landscape, conclusive evidence regarding the shortand long-term health effects—both harms and benefits—of cannabis use remains elusive.Abstract:
Recent years have seen a rapid rise in the medical and recreational use of cannabis: a broad term that can be used to describe the various products and chemical compounds (e.g., marijuana, cannabinoids) derived from different species of the cannabis plant. Despite increased cannabis use and a changing state-level policy landscape, conclusive evidence regarding the shortand long-term health effects—both harms and benefits—of cannabis use remains elusive.read more
Citations
More filters
Journal ArticleDOI
The effect of medical cannabis laws on pharmaceutical marketing to physicians.
TL;DR: The authors examined the strategic response in direct-to-physician marketing by pharmaceutical firms as medical cannabis enters the market and found weak evidence of a relatively small and delayed response in substitute prescription drug- and opioid-related detailing.
Journal ArticleDOI
Association between daily and non-daily cannabis use and depression among United States adult cancer survivors
TL;DR: In this article, the prevalence of daily/non-daily CU, investigate the association between CU and depression and evaluate CU reasons and methods of administration among cancer survivors among cancer patients.
Journal ArticleDOI
Self-Reported Medical and Nonmedical Cannabis Use: Results from the 2018 Behavioral Risk Factor Surveillance System in 14 States
TL;DR: For instance, the authors found that 28.6% of adults who use cannabis reported using cannabis medically, 34.2% (95% CI: 32.3, 36.2, 39.2) non-medically, and 37.2 % reported using both medical and non-medical reasons.
Journal ArticleDOI
Online survey of medicinal cannabis users: Qualitative analysis of patient-level data
Albert Garcia-Romeu,Joshua Ryan Elmore,Rhiannon E. Mayhugh,Nicolas J. Schlienz,Erin L. Martin,Justin C. Strickland,Marcel O. Bonn-Miller,Heather M. Jackson,Ryan Vandrey +8 more
TL;DR: Most participants reported benefits from cannabis use for a variety of conditions where traditional treatments were ineffective or unacceptable, and concerns regarding cannabis side effects, legality, lack of information, and cost were raised.
Journal ArticleDOI
The Compassionate Utilitarian: Reconciling the Competing Moral Values Behind Efforts to Regulate Cannabis Use
TL;DR: The authors argue that the legalization debate is actually a variation of long-running debates about harm reduction strategies in public health, which are about deeper concerns that won't be resolved with more data.
References
More filters
Journal ArticleDOI
Diagnostic and Statistical Manual of Mental Disorders
Vijay A. Mittal,Elaine F. Walker +1 more
TL;DR: An issue concerning the criteria for tic disorders is highlighted, and how this might affect classification of dyskinesias in psychotic spectrum disorders.
Journal ArticleDOI
Systematic Review: Process of Forming Academic Service Partnerships to Reform Clinical Education
TL;DR: This study’s findings can provide practical guidelines to steer partnership programs within the academic and clinical bodies, with the aim of providing a collaborative partnership approach to clinical education.
Journal ArticleDOI
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
Julian P T Higgins,Douglas G. Altman,Peter C Gøtzsche,Peter Jüni,David Moher,Andrew D Oxman,Jelena Savović,Kenneth F. Schulz,Laura Weeks,Jonathan A C Sterne +9 more
TL;DR: The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate.
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
TL;DR: The Newcastle-Ottawa Scale (NOS) as discussed by the authors was developed to assess the quality of nonrandomised studies with its design, content and ease of use directed to the task of incorporating the quality assessments in the interpretation of meta-analytic results.
Journal ArticleDOI
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Theresa Hm Moore,Stanley Zammit,Stanley Zammit,Anne Lingford-Hughes,Thomas R. E. Barnes,Peter B. Jones,Margaret Burke,Glyn Lewis +7 more
TL;DR: There is now sufficient evidence to warn young people that using cannabis could increase their risk of developing a psychotic illness later in life, although evidence for affective outcomes is less strong.